✦ LIBER ✦

Cognitive effects of a prolonged-release formulation of galantamine (PRC) in patients with alzheimer's disease (AD) - an open-label phase-IIIb-study

✍ Scribed by Gerwe, M.; Ibach, B.; Czekalla, J.; Moeller, H.J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cognitive function in patients with alzh

✍ Ibach, B.; Gerwe, M.; Schwalen, S.; Riepe, M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 French ⚖ 58 KB

A 6-month open-label study of the effect

✍ C.E. Patterson; A.P. Passmore; V.L.S. Crawford 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Disease progression in patients with mil

✍ Gaudig, Maren; Richarz, Ute; Rettig, Klaus; Djelani, Miriam; Schauble, Barbara 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 52 KB

A long-term, open-label extension study

✍ Perhach, James; Graham, Stephen 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Effectiveness of an outpatient cognitive

✍ Rojas, Galeno; Demey, Ignacio; Feldberg, Carolina; Leis, Adriana; Saux, Gaston; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 80 KB

P.5.a.006 Long-term safety and tolerabil

✍ S. Bakchine; M. Rainer 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB